4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-033269
CEO and CFO bought 4,000 shares at $8.95 ($35,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-09-19 | Purchase | +4,000 | $8.95 | $35,800 | 5,296,177 | D |
| Open-market purchases · 4,000 sh · avg $8.95 · $35,800 | |||||||
Loading xslF345X05/ownership.xml…